Sektor Caplin Point Laboratories Limited

Aktien

A2DSTM

INE475E01026

CAPLIPOINT

Pharmazeutika

Verzögert 08:01:07 17.11.2026 Perf. 5 T Veränd. 1. Jan.
2’378.10 INR +1.44% Intraday Chart für Caplin Point Laboratories Limited -5.75% +29.05%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+1.44%-5.75%+5.04%-5.73%+29.05%+22.18%+84.74%+176.41%+563.13% 1.9 Mrd.
-0.82%+1.40%+13.89%+21.31%+33.22%+39.64%+143.17%+455.51%+1’760.76% 1’275 Mrd.
-1.12%+0.16%+10.56%+8.53%+36.53%+44.21%+88.24%+73.70%+142.82% 680 Mrd.
-0.16%+0.43%+3.20%+18.08%+28.91%+26.76%+113.01%+153.01%+378.63% 521 Mrd.
+1.14%+2.04%+7.94%+15.26%+24.71%+43.06%+72.81%+10.88%+76.19% 389 Mrd.
-2.23%-2.89%-1.02%+6.35%+37.24%+55.47%+41.64%+71.75%+130.66% 356 Mrd.
+1.27%+1.72%+8.87%+10.88%+23.87%+30.01%+63.11%+77.46%+88.03% 305 Mrd.
+0.37%-0.23%+12.76%+22.46%+1.77%+3.71%+38.05%+63.15%+222.36% 287 Mrd.
-0.72%-0.63%+6.90%+11.35%+41.25%+37.29%+71.87%+125.09%+214.01% 250 Mrd.
-0.30%-1.03%+7.29%+21.12%+36.53%+34.04%+124.88%+150.53%+120.50% 208 Mrd.
+2.44%+4.56%+9.88%-3.21%-12.30%-8.29%-57.95%-24.04%+147.18% 185 Mrd.
-0.10%-1.27%-2.43%+7.73%+15.90%+15.16%-3.06%-41.81%-9.70% 164 Mrd.
-0.15%-2.37%+7.61%+6.34%+18.62%+23.02%+56.79%+185.56%+494.44% 136 Mrd.
-0.79%+1.27%+5.32%-1.41%+16.67%+34.90%+23.78%+6.48%+11.98% 129 Mrd.
+0.20%+4.31%+9.97%+27.16%+34.71%+31.23%+145.14%+400.90%+681.06% 128 Mrd.
+0.82%+2.99%+22.77%+16.95%+6.77%-1.42%+4.13%-2.05%+13.83% 116 Mrd.
+0.94%+1.31%+3.60%+6.16%+5.76%+8.16%+39.62%-0.92%+1.15% 102 Mrd.
-0.32%+3.53%+20.44%+18.53%+23.39%+37.33%+19.57%+48.18%+126.72% 95.57 Mrd.
-3.63%-19.97%-1.26%+239.97%+629.98%+769.08%+181.21%-8.11% - 87.1 Mrd.
-0.54%+2.49%+15.88%+6.93%-10.95%-13.68%+49.70%+76.82%+562.26% 76.08 Mrd.
Durchschnitt -0.12%-0.25%+8.36%+22.74%+51.08%+61.59%+65.02%+99.92%+301.37% 275 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt -0.34%+0.63%+8.99%+17.88%+36.04%+43.78%+84.27%+167.57%+559.43%
  1. Börse
  2. Aktien
  3. A2DSTM Aktie
  4. Sektor Caplin Point Laboratories Limited